Artificial intelligence for natural product drug discovery and development: current landscape, applications, and future directions
Zhinya Kawa Othman(Kurdistan Regional Government), Sornkanok Vimolmangkang(Chulalongkorn University), Shuaibu Saidu Musa(Ahmadu Bello University), Francesco Branda(Università Campus Bio-Medico), Don Eliseo Lucero‐Prisno(Bukidnon State University), Omar Kasimieh(University of the East Ramon Magsaysay Memorial Medical Center), Mohamed Mustaf Ahmed(Chulalongkorn University), Edgar G. Cue(Instituto de Montañas), Justine Marie A. Ocampo(University of Makati)
Cited by 9
Related Papers
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
|Cancers|2022|303
Updated epidemiology of gastrointestinal cancers in East Asia
|Nature Reviews Gastroenterology & Hepatology|2023|258
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
|The Lancet Haematology|2022|208
Impact of COVID‐19 on access to healthcare in low‐ and middle‐income countries: Current evidence and future recommendations
|The International Journal of Health Planning and Management|2020|172
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
|Tropical Medicine and Health|2021|153